Former AXA Framlington Biotechnology fund manager Andy Smith has joined biopharma specialist Mann Bioinvest to launch an income-focused fund in the coming weeks.
We believe 2013 is shaping up positively for global equity income investors after the New Year's Day Tax Agreement by US politicians which partly resolved the fiscal cliff.
Traditionally only available to institutional investors and high-net-worth individuals, Jock Green-Armytage, investment adviser to JZ Capital Partners Limited, explains how smaller retail investors can gain exposure.
The FTSE 100 has started to recover during this morning's trading, after its first poor finish since the start of the year on Monday.
Emerging market stocks rose for the ninth day in a row today on increased investor confidence, driven by positive data from China and the US.
Like a phoenix rising from the ashes, the battered financials sector is back to delivering double-digit returns after having its wings severely clipped by the financial crisis.